Clinical Trial Update: Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine [Phase 3]

View source ↗

Summary

Phase 3 trial of ranolazine SR in chronic angina patients who remain symptomatic despite maximal amlodipine treatment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina

Drugs mentioned

• Ranolazine SR (Ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Angina | Phase 3 | Status: COMPLETED